OXY Overnight Acne Reducing Patches

Manufacturer
The Mentholatum Company
Effective date
2024-12-17
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
legacy-cache
Hydrated at
2026-08-01 20:45:38

Label at a glance#

ProductOXY Overnight Acne Reducing Patches
Active ingredientSALICYLIC ACID
Label structure9 sections

Indications and uses

treats and helps prevent acne

Dosage and administration

cleanse skin thoroughly before applying this product apply patch(es) to affected area(s) to remove, gently peel back patch and discard because excessive drying of the skin may occur, start with 1 application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 0.5%

Purpose

OTC - PURPOSE SECTION

Salicylic acid - Acne treatment

Uses

INDICATIONS & USAGE SECTION

treats and helps prevent acne

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

  • keep away from eyes, lips and mouth. If contact occurs, flush thoroughly with water.
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
If pregnant or breast-feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • cleanse skin thoroughly before applying this product
  • apply patch(es) to affected area(s)
  • to remove, gently peel back patch and discard
  • because excessive drying of the skin may occur, start with 1 application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Inactive ingredients

INACTIVE INGREDIENT SECTION

acrylates/ethylhexyl acrylate copolymer, water, nonoxynol-30, alcohol denatured, butylene glycol, C13-14 isoparaffin, epilobium angustifolium flower/leaf/stem extract, kaolin, laureth-7, melaleuca alternifolia (tea tree) leaf oil, phenoxyethanol, phytosphingosine, polysorbate 80, PVP, sodium hyaluronate, sodium hydroxide, sodium metabisulfite, sodium polyacrylate, vitis vinifera (grape) seed extract, volcanic ash

Questions?

OTC - QUESTIONS SECTION

1-877-636-2677 MON-FRI 9 AM - 5 PM (EST)

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Oxy Overnight Acne Reducing Patches
Oxy Overnight Acne Reducing Patches

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Drug Facts
Drug Facts

FDA-Initiated Inactive NDC Indexing#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10742-8177OXY OVERNIGHT ACNE REDUCING PATCHES (SALICYLIC ACID) PATCH [THE MENTHOLATUM COMPANY]8Legacy NDC20241219_d9652f3f-bb6e-4d74-88d6-d4dbaa3de22d.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10742-817710742-8177-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4402a388-02da-0605-e063-6394a90a8992d9652f3f-bb6e-4d74-88d6-d4dbaa3de22d2025-11-20WarningsExact identifier
spl set id: d9652f3f-bb6e-4d74-88d6-d4dbaa3de22d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.